Editorial: covert hepatic encephalopathy-silent but serious. Authors' reply

C Labenz^{1

2}, M-A Wörns^{1

2}

Affiliations

¹ Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.
² Cirrhosis Centre Mainz (CCM), University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.

Editorial

C Labenz et al. Aliment Pharmacol Ther. 2018 Aug.

. 2018 Aug;48(4):480-481.

doi: 10.1111/apt.14867.

C Labenz^{1

2}, M-A Wörns^{1

2}

¹ Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.
² Cirrhosis Centre Mainz (CCM), University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.

No abstract available

Comment on

Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
Labenz C, Baron JS, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA. Labenz C, et al. Aliment Pharmacol Ther. 2018 Aug;48(3):313-321. doi: 10.1111/apt.14824. Epub 2018 Jun 4. Aliment Pharmacol Ther. 2018. PMID: 29863286
Editorial: covert hepatic encephalopathy-silent but serious.
Neuberger J. Neuberger J. Aliment Pharmacol Ther. 2018 Aug;48(4):479-480. doi: 10.1111/apt.14857. Aliment Pharmacol Ther. 2018. PMID: 30588699 No abstract available.